Connor, Clark & Lunn Investment Management Ltd. Adaptive Biotechnologies Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $28.9 Billion
- Q3 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 55,944 shares of ADPT stock, worth $812,866. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,944Holding current value
$812,866% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding ADPT
# of Institutions
275Shares Held
148MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$436 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$169 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$164 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$90.9 Million1.68% of portfolio
-
Braidwell LP Stamford, CT3.86MShares$56.1 Million2.76% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.08B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...